Translating evidence into policy in China: opportunities and challenges

doi:10.1007/s11684-011-0146-6

Front Med

2011, Vol. 5

Issue (3) : 315-320 https://doi.org/10.1007/s11684-011-0146-6

COMMENTARY

Translating evidence into policy in China: opportunities and challenges

Jiyao Wang^1,3(

), Xuejuan Jin^2,3

1. Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 2. Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 3. Center of Clinical Epidemiology and Evidence-based Medicine, Fudan University, Shanghai 200032, China

Download: PDF(121 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Research and evidence are critical for the formulation of policies and practices in support of health care. In the past two decades, the Chinese Clinical Epidemiology Network has been promoting evidence-based policy making in China. Evidence-based policy has become a major part of the government’s approach to policy making. The current article addresses the translation of evidence into health policies based on the expansion of evidence-based medicine in China. It also discusses the opportunities and challenges for certain evidence to be considered in policy making and practice in the future.

Keywords clinical epidemiology evidence-based decision making policy

Corresponding Author(s): Wang Jiyao,Email:wang.jiyao@zs-hospital.sh.cn

Issue Date: 05 September 2011

Cite this article:

Jiyao Wang,Xuejuan Jin. Translating evidence into policy in China: opportunities and challenges[J]. Front Med, 2011, 5(3): 315-320.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-011-0146-6
https://academic.hep.com.cn/fmd/EN/Y2011/V5/I3/315

Tab.1 Chinese Clinical Epidemiology Network (ChinaCLEN)

Fig.1 Chinese medicine clinical research platform.

Fig.2 A new paradigm for the 21st century.

Fig.3 Evidence sources and knowledge management.

1	Wang J. Evidence-based medicine. Chin J Intern Med (Zhonghua Nei Ke Za Zhi) 2000; 39(4): 279–280 (in Chinese)
2	Wang J. Evidence-based medicine in China. Lancet 2010; 375(9714): 532–533 doi: 10.1016/S0140-6736(09)62131-0 pmid:20159275
3	The Lancet. Reforming research in China. Lancet 2007; 369(9565): 880 doi: 10.1016/S0140-6736(07)60419-X pmid:17368128
4	Guo L. China boosts medical research. Lancet 2010; 375(9716): 711 doi: 10.1016/S0140-6736(10)60288-7 pmid:20201132
5	Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, Xu G, Zhu S, Yao C, Jiang L, Miao J, Zhang H, Zhao D, Liu X, Yao Y. Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med 2009; 360(11): 1067–1074 doi: 10.1056/NEJMoa0809550 pmid:19196669
6	Bian Z, Liu B, Moher D, Wu T, Li Y, Shang H, Cheng C. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Front Med 2011; 5(2): 171–177 doi: 10.1007/s11684-011-0132-z pmid:21695622
7	Wang SC, Liu JP, Li H, Yu H. Guidelines for evidence-based Chinese medicine clinical pathway report. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2010; 8(9): 819–823 (in Chinese) doi: 10.3736/jcim20100903 pmid:20836970
8	Zhou X, Chen S, Liu B, Zhang R, Wang Y, Li P, Guo Y, Zhang H, Gao Z, Yan X. Development of traditional Chinese medicine clinical data warehouse for medical knowledge discovery and decision support. Artif Intell Med 2010; 48(2-3): 139–152 doi: 10.1016/j.artmed.2009.07.012 pmid:20122820
9	Wang Y, Liu B, Xie Y. Establishing appraisal mechanism of clinic studies in traditional Chinese medicine with proofing medicine methodology. Chin J Basic Med Tradit Chin Med (Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi) 2003; 9(3): 17–23 (in Chinese)
10	Liu B, Zhang Y, Hu J, He L, Zhou X. Thinking and practice of accelerating transformation of traditional Chinese medicine from experience medicine to evidence-based medicine. Front Med 2011; 5(2):163–170 doi: 10.1007/s11684-011-0143-9 pmid:21695621
11	Wang N. Current status of evidence-informed health decision-making and the establishment of priority issue in the evidence-informed health decision-making network. Dissertation for Master’s Degree . Ji’nan: Shandong University, 2007 (in Chinese)
12	Wang J, Gluud C. Evidence-based Medicine and Clinical Practice. 2nd . Beijing: Science Press. 2006 (in Chinese)
13	Wang Y, Wang CM. Diagnosis and treatment guidelines for acute fever of unknown etiology in Chinese children aged 0 to 5. Chin J Evid Based Pediatr (Zhongguo Xun Zheng Er Ke Za Zhi) 2008; 11(3): 449–457 (in Chinese)
14	Wang J. Correct the misconceptions about evidence-base medicine. Natl Med J China (Zhonghua Yi Xue Za Zhi) 2004; 84(12): 969–970 (in Chinese) pmid:15312526
15	Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials 2009; 10(1): 46 doi: 10.1186/1745-6215-10-46 pmid:19573242
16	Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy. Bull World Health Organ 2011; 89(4): 312–316 doi: 10.2471/BLT.10.077743 pmid:21479096
17	Aldridge RW, Cole KJ, Hurst L, McKee M, Horton R. Lancet UK policy matters: better evidence for better health. Lancet 2011; 377(9778): 1631–1633 doi: 10.1016/S0140-6736(11)60652-1 pmid:21571133

[1]	Qiang Li, Dongrui Deng. New medical risks affecting obstetrics after implementation of the two-child policy in China[J]. Front. Med., 2017, 11(4): 570-575.
[2]	Chunsong Hu,Qinghua Wu. Health: a dream from reality to the future[J]. Front. Med., 2016, 10(2): 233-235.
[3]	Douglas Sipp. The unregulated commercialization of stem cell treatments: a global perspective[J]. Front Med, 2011, 5(4): 348-355.

Viewed

Full text

Abstract

Cited

Shared

Discussed